🇺🇸 FDA
Patent

US 6350785

Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors

expired A61KA61K31/00A61K31/203

Quick answer

US patent 6350785 (Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors) held by Maxim Pharmaceuticals, Inc. expires Mon Feb 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Maxim Pharmaceuticals, Inc.
Grant date
Tue Feb 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/00, A61K31/203, A61K31/4045, A61K31/417